SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

4 h delay

Buys Sells Buys and sells Any size $100K+$1M+

Pro filters

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.4B−889.0%Mar 10

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$34KJan 20

MYOVSell

Myovant Sciences Ltd.

Lauren Merendino · Chief Commercial Officer

$54K−1.0%Jan 20

MYOVSell

Myovant Sciences Ltd.

David C Marek · Principal Exec Officer

$216K−2.0%Jan 20

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$30KJan 20

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$75K−1.0%Jan 5

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$61K−1.0%Jan 5

MYOVSell

Myovant Sciences Ltd.

Uneek Mehra · Principal Financial Officer

$60K−1.0%Dec 20

MYOVSell

Myovant Sciences Ltd.

Lauren Merendino · Chief Commercial Officer

$43K−1.0%Oct 20

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$49K−1.0%Oct 20

MYOVSell

Myovant Sciences Ltd.

David C Marek · Principal Exec Officer

$281K−3.0%Oct 20

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$40K−1.0%Oct 20

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$90K−1.0%Oct 6

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$67K−1.0%Oct 6

MYOVSell

Myovant Sciences Ltd.

Uneek Mehra · Principal Financial Officer

$174K−4.0%Sep 20

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$569K−8.0%Aug 16

MYOVSell

Myovant Sciences Ltd.

David C Marek · Principal Exec Officer

$144K−2.0%Jul 20

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$50K−1.0%Jul 8

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$37K−1.0%Jul 8

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$84K−3.0%Apr 21

MYOVSell

Myovant Sciences Ltd.

Lauren Merendino · Chief Commercial Officer

$74K−4.0%Apr 21

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$48K−2.0%Apr 21

MYOVSell

Myovant Sciences Ltd.

David C Marek · Principal Exec Officer

$257K−5.0%Apr 21

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$34K−1.0%Apr 7

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$26K−1.0%Apr 7

MYOVSell

Myovant Sciences Ltd.

David C Marek · Principal Exec Officer

$292K−6.0%Jan 21

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$73K−2.0%Jan 6

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$37K−1.0%Jan 6

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$38K−1.0%Dec 1

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$91K−2.0%Nov 5

MYOVSell

Myovant Sciences Ltd.

Matthew Lang · GC, Corp. Secy.

$144K−4.0%Oct 7

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$59K−2.0%Oct 7

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$472KSep 30

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$170K−4.0%Sep 29

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.0MSep 28

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$3.1MSep 24

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.8MSep 22

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.0MSep 20

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$3.6MSep 16

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.7MSep 14

MYOVSell

Myovant Sciences Ltd.

Terrie Curran · Director

$124K−100.0%Sep 13

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.5MSep 10

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.7MSep 8

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.6MSep 3

MYOVSell

Myovant Sciences Ltd.

Terrie Curran · Director

$1.2M−100.0%Sep 3

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.6MSep 1

MYOVSell

Myovant Sciences Ltd.

Ferreira Juan Camilo Arjona · Chief Medical Officer

$550K−12.0%Aug 31

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.8MAug 30

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$1.4MAug 26

MYOVBuy

Myovant Sciences Ltd.

Sumitomo Chemical Co., Ltd. · 10% owner

$2.2MAug 24

Older filings

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.